𝔖 Bobbio Scriptorium

✦ LIBER ✦

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

✍ Scribed by Richard A. Nash; Razelle Kurzrock; John DiPersio; Julie Vose; Charles Linker; Dipnarine Maharaj; Auayporn P. Nademanee; Robert Negrin; Stephen Nimer; Howard Shulman; Mark Ashby; Dennie Jones; Frederick R. Appelbaum; Richard Champlin

Book ID: 117727853
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 114 KB
Volume: 6
Category: Article
ISSN: 1083-8791
DOI: 10.1016/s1083-8791(00)70049-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-Hematopoietic Stem Cell Transplanta

Post-Hematopoietic Stem Cell Transplantation (HSCT) Outcomes in Patients With AML Transplanted Prior to Achieving Platelet Recovery

✍ G. Alatrash; M. Pelosini; R. Saliba; G. Rondon; W. Zhang; S. Giralt; P. Kebriaei 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The immature platelet fraction is a usef

The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation

✍ G. YAMAOKA; Y. KUBOTA; T. NOMURA; T. INAGE; T. ARAI; A. KITANAKA; K. SAIGO; K. I 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Phase I study of a neutralizing monoclon

Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantation

✍ A. Bashey; B. Medina; R.-K. Zhong; J.-H. Zhou; E. Carrier; J. Castro; P. Holman; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Results of Phase II Clinical Trial MPD-R

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

✍ D. Rondelli; J.D. Goldberg; R. Marchioli; L. Isola; T.B. Shore; J.T. Prchal; A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase I/II Multicenter Clinical Trial of

Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)

✍ Becker, Pamela S.; Alsina, Melissa; Zhong, Xiaobo; Hari, Parameswaran N.; Rowley 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A phase I/II study of xcellerated T cell

A phase I/II study of xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma

✍ T. Martin; R. Vij; R. Vescio; I. Borrello; D. Siegel; A. Bashey; J. DiPersio; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 67 KB